Children's National Medical Center
- Advisory Board: Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Shionogi Inc.
- Consultant: H. Lundbeck A/S
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Research Support: Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institute of Child Health and Human Development; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Schering-Plough; Sepracor Inc.; Supernus Pharmaceuticals, Inc.
- Royalties: Epocrates Inc.
- Speakers Bureau: Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Pfizer Inc; Sepracor Inc.